Aigen Investment Management, LP Cytokinetics Inc Transaction History

Aigen Investment Management, LP

  • $487 Million
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
BUY
$47.86 - $75.05 $328,798 - $515,593
6,870 Added 64.49%
17,523 $949,000
Q1 2024

May 14, 2024
BUY
$63.75 - $108.06 $679,128 - $1.15 Million
10,653 New
10,653 $746,000
Q3 2020

Nov 06, 2020
SELL
$20.58 - $28.96 $955,158 - $1.34 Million
-46,412 Closed
0 $0
Q2 2020

Aug 10, 2020
BUY
$11.15 - $24.64 $296,065 - $654,265
26,553 Added 133.71%
46,412 $1.09 Million
Q1 2020

May 08, 2020
BUY
$8.75 - $16.3 $7,446 - $13,871
851 Added 4.48%
19,859 $234,000
Q4 2019

Feb 04, 2020
BUY
$7.95 - $11.84 $151,113 - $225,054
19,008 New
19,008 $202,000

Others Institutions Holding CYTK

# of Institutions
410
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.73B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email